Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis. [electronic resource]
Producer: 20161213ISSN:- 1757-790X
- Abatacept -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Cyclosporine -- therapeutic use
- Glomerulosclerosis, Focal Segmental -- drug therapy
- Glucocorticoids -- therapeutic use
- Humans
- Immunosuppressive Agents -- therapeutic use
- Male
- Middle Aged
- Prednisolone -- therapeutic use
- Rituximab -- therapeutic use
- Treatment Failure
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.